Literature DB >> 16169261

The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.

B Mwaura1, B Mahendran, N Hynes, D Defreitas, G Avalos, T Adegbola, M Adham, C E Connolly, S Sultan.   

Abstract

INTRODUCTION: Alteration in the expression of extracellular matrix metalloproteinase inducer (EMMPRIN), matrix metalloproteinase-2 (MMP-2), tissue inhibitors of matrix metalloproteinases (TIMP-2) and platelet derived growth factor (PDGF-AA) may contribute to poor healing in venous leg ulcers. AIM: The aim of this study is to determine the expression of EMMPRIN, MMP-2, TIMP-2 and PDGF-AA in the ulcer exudates and perivascular tissue of healing and non-healing chronic venous ulcers. PATIENTS,
MATERIALS AND METHODS: Forty patients with chronic venous ulcers were included in this study, with a mean age of 60 years. Eleven patients were males and 29 were females. All patients had normal ankle brachial index and a venous ulcer of at least 8 weeks duration. Immuno-histochemistry using monoclonal antibodies to PDGF-AA, MMP-2, TIMP-2 and EMMPRIN was carried out on paraffin embedded punch biopsy skin specimens from the ulcer edge. Enzyme linked immunosorbent assay for PDGF, MMP-2 and TIMP-2 were carried out on wound fluids collected from patients. The ulcer size and character at the initial assessment and after 8 weeks were assessed to determine the status of ulcer healing.
RESULTS: No significant difference was seen in the expression of TIMP-2, MMP-2 and EMMPRIN between the two groups. However, in the non-healing group high levels of MMP-2 and low levels of TIMP-2 in the wound fluid suggest a strong correlation of these two markers in the state of healing. Analysis of wound fluid by ELISA demonstrated high PDGF-AA in the healing group (p = 0.021). Significantly increased levels of PDGF-AA (p<0001) was noted in the perivascular area on immuno-histochemistry of healing ulcers. These data suggest that PDGF-AA plays an important role in healing of venous ulcers.
CONCLUSION: Non-healing venous ulcers are associated with greater activity MMP-2 activity. The ratio of MMPs to their inhibitors TIMPs, dictate the rate of healing of the ulcers. PDGF-AA activity is associated with ulcer healing, though the mechanism is unclear. EMMPRIN expression in chronic venous ulcers probably parallels the chronicity of the condition rather than propagate it. However, further studies with larger samples are needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16169261     DOI: 10.1016/j.ejvs.2005.08.007

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  21 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

2.  A comparison of the in vitro moisture vapour transmission rate and in vivo fluid-handling capacity of six adhesive foam dressings to a newly reformulated adhesive foam dressing.

Authors:  Cindy L Zehrer; David Holm; Staci E Solfest; Shelley-Ann Walters
Journal:  Int Wound J       Date:  2013-01-30       Impact factor: 3.315

Review 3.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 4.  Interaction of the microbiome with the innate immune response in chronic wounds.

Authors:  Elizabeth A Grice; Julia A Segre
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 5.  Dynamic reciprocity in the wound microenvironment.

Authors:  Gregory S Schultz; Jeffrey M Davidson; Robert S Kirsner; Paul Bornstein; Ira M Herman
Journal:  Wound Repair Regen       Date:  2011 Mar-Apr       Impact factor: 3.617

6.  Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

Authors:  Ferdinando Mannello; Joseph D Raffetto
Journal:  Am J Transl Res       Date:  2010-11-23       Impact factor: 4.060

7.  Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial.

Authors:  Jean-Luc Schmutz; Sylvie Meaume; Ségolène Fays; Zohva Ourabah; Bernard Guillot; Valéne Thirion; Mark Collier; Simon Barrett; J Smith; Serge Bohbot; Anne Dompmartin
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

Review 8.  Neutrophil activity in chronic venous leg ulcers--a target for therapy?

Authors:  Jodi C McDaniel; Sashwati Roy; Traci A Wilgus
Journal:  Wound Repair Regen       Date:  2013-03-28       Impact factor: 3.617

9.  Burn injury reveals altered phenotype in mannan-binding lectin-deficient mice.

Authors:  Mette Møller-Kristensen; Michael R Hamblin; Steffen Thiel; Jens Chr Jensenius; Kazue Takahashi
Journal:  J Invest Dermatol       Date:  2007-03-15       Impact factor: 8.551

10.  Role of matrix metalloproteinases in non-healing venous ulcers.

Authors:  Bruno Amato; Guido Coretti; Rita Compagna; Maurizio Amato; Gianluca Buffone; Diego Gigliotti; Raffaele Grande; Raffaele Serra; Stefano de Franciscis
Journal:  Int Wound J       Date:  2013-10-24       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.